FOURKITES
6.4.2022 10:38:09 CEST | Business Wire | Press release
FourKites ® , the #1 real-time supply chain visibility platform, today launches Slot Manager, its universal time slot booking solution, across Europe. The cloud-based solution helps warehouses, distribution centers and manufacturing facilities collaborate efficiently on pickup and receiving time slots, saving significant time and improving daily operations and partner relationships. In addition, the highly configurable solution allows shippers and carriers to eliminate excess dwell time on site, eliminating detention fees and significantly reducing carbon emissions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220406005544/en/
Time slot management is a notoriously time-consuming task for shippers and carriers alike. With carrier dwell averaging up to 4.35 hours per day, or nearly half of a driver’s time, Slot Manager improves facility productivity and reduces carrier wait time by more than 50%. Highly configurable for personalised requirements, Slot Manager enables shippers and carriers to collaborate in real time, and allows carriers to self-book their preferred time slot based on real-time transit conditions, thereby eliminating hours of daily administrative work and error-prone manual processes.
Slot Manager is an extension of FourKites’ Appointment ManagerSM , launched over two years ago. The solution is now also available in several new Asia-Pacific markets, including Australia, New Zealand and India.
Specifically, Slot Manager offers the following benefits:
- Labor optimisation : Leveraging FourKites’ Dynamic ETA® to provide the most accurate times of arrival, teams can better allocate labor and resources based on real-time data and shifts in expected arrival time.
- Ease and compliance with carrier scheduling : Slot Manager creates a single appointment layer accessible to both shippers and carriers to streamline communication and facilitate collaboration. Slots are created by the facility to ensure adherence to preferred scheduling, business rules and specific commodity requirements.
- True end-to-end visibility : Powered by real-time supply chain visibility data from FourKites, Slot Manager extends visibility even further into the facility via one streamlined interface. With FourKites, stakeholders receive a comprehensive end-to-end view of shipments from point of origin to predictive insights that help orchestrate activities in the facility.
- Diminished carrier detention costs : With optimised scheduling, carrier dwell on site can be virtually eliminated, helping shippers avoid detention fees and fines for truck queues on public roads.
- Reduced carbon emissions : Scheduling and operational efficiencies driven by Slot Manager reduce time carriers spend in the yard by up to 50%, cutting carbon dioxide emissions by an average of 54%.
“We are excited to introduce the easiest, most flexible slot booking application on the market,” said Mathew Elenjickal, FourKites Founder and CEO. “This groundbreaking solution helps shippers across the globe optimise end-to-end visibility, efficiency and sustainability, as well as adapt quickly as their business needs change. We’re thrilled to be launching Slot Manager in Europe, specifically tailored to the needs of local facilities.”
In addition, FourKites has partnered with French transportation solutions firm IER , a Blue Systems entity (Bolloré Group), to facilitate integrated implementation in Europe, driving greater efficiency for both carriers and facilities. The partnership combines IER’s leading standard of facility hardware technology with facility processes for automated check-in and check-out. When combined with FourKites’ advanced data capture and processing capabilities, the companies’ combined pre-configured integration offers a fast, turnkey facility solution for customers.
"We chose to partner with FourKites due to their globally recognised data quality and their commitment to delivering that data back to customers with actionable insights," said Christophe Levy, Chief Executive Officer of IER’s Track & Trace Unit. "By combining FourKites’ advanced supply chain intelligence capabilities with our leading facility hardware capabilities, we offer a seamlessly integrated solution that helps customers achieve immediate results for their business."
About FourKites
FourKites® is the #1 supply chain visibility platform in the world, extending visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.5 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching more than 185 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,000 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220406005544/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 03:00:00 CEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 00:00:00 CEST | Press release
On average, about 75% of patients with scalp psoriasis treated with zasocitinib achieved clear or almost clear skin at week 16 Approximately 70% of patients with palmoplantar disease treated with zasocitinib achieved clear or almost clear skin at week 16 Zasocitinib demonstrated statistically significant improvements in Nail Psoriasis Severity Index (NAPSI) versus placebo Results reinforce the potential of zasocitinib to deliver rapid and durable skin clearance, including in the hardest-to-treat areas, in a convenient once-daily pill Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance16.7.2026 23:36:00 CEST | Press release
Debut transaction more than three times oversubscribed The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful plac
The Estée Lauder Companies Appoints Madeleine Boyd as Senior Vice President, Global Brand Communications16.7.2026 22:22:00 CEST | Press release
The Estée Lauder Companies Inc. (NYSE: EL) today announced the appointment of Madeleine Boyd as Senior Vice President, Global Brand Communications, effective July 20, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716738393/en/ Photo by Esteban La Tessa As part of the company’s continued efforts to strengthen how its brands better connect with consumers, Ms. Boyd will establish and lead a newly integrated Global Brand Communications team. In this role, she will ensure the company’s diverse portfolio is anchored by a cohesive enterprise communications strategy, while accelerating bold, consumer-first storytelling that drives earned media, cultural relevance, and brand desirability. She will also strengthen creator engagement, helping the company’s brands gain attention where culture is being shaped. Ms. Boyd brings extensive experience spanning brand strategy, communications, consumer engagement, and cultural insight
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom